PHLDA1 and colorectal cancer: Another contrasting function of PHLDA1 emerged in HCT116, HT29, and SW48 colorectal cancer cells, where PHLDA1 upregulation was associated with resistance to cetuximab, a monoclonal antibody targeting EGFR (Park et al. 2019).